An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination.

Saved in:
Bibliographic Details
Title: An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination.
Authors: BRABANTS, E.1 Elisabeth.Brabants@ugent.be, HEYNS, K.1, SMET, S. DE2, DEVREKER, P.2, INGELS, J.2, CABOOTER, N. DE1,3, DEBACKER, V.1,3, DULLAERS, M.1,3, VAN MEERBEECK, J.P.4, VANDEKERCKHOVE, B.2, VERMAELEN, K.Y.1
Source: Cytotherapy (Elsevier Inc.). Sep2018, Vol. 20 Issue 9, p1164-1181. 18p.
Database: Academic Search Ultimate
Description
ISSN:14653249
DOI:10.1016/j.jcyt.2018.06.006